{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:53:01Z","timestamp":1787917981002,"version":"build-2784847793"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Percutaneous coronary intervention, which is safe, effective, and timely, has become an important treatment for coronary artery diseases and has been widely used in clinical practice. However, there are still some problems that urgently need to be solved. Permanent vessel caging through metallic implants not only prevents the process of positive vessel remodeling and the restoration of vascular physiology but also makes the future revascularization of target vessels more difficult. Bioresorbable scaffolds (BRSs) have been developed as a potential solution to avoid the above adverse reactions caused by permanent metallic devices. BRSs provide temporary support to the vessel wall in the short term and then gradually degrade over time to restore the natural state of coronary arteries. Nonetheless, long-term follow-up of large-scale trials has drawn considerable attention to the safety of BRSs, and the significantly increased risk of late scaffold thrombosis (ScT) limits its clinical application. In this review, we summarize the current status and clinical experiences of BRSs to understand the application prospects and limitations of these devices. In addition, we focus on ScT after implantation, as it is currently the primary drawback of BRS. We also analyze the causes of ScT and discuss improvements required to overcome this serious drawback and to move the field forward.<\/jats:p>","DOI":"10.3389\/fcvm.2020.589571","type":"journal-article","created":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T23:34:05Z","timestamp":1606692845000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Bioresorbable Scaffolds: Contemporary Status and Future Directions"],"prefix":"10.3389","volume":"7","author":[{"given":"Xiang","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1093\/eurheartj\/ehz698","article-title":"Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis","volume":"41","author":"Freisinger","year":"2019","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMc1711903","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","volume":"377","author":"Waksman","year":"2017","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jacc.2015.11.060","article-title":"A polylactide bioresorbable scaffold eluting everolimus for treatment of coronary stenosis: 5-year follow-up","volume":"67","author":"Serruys","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jcin.2013.05.017","article-title":"Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial","volume":"6","author":"Onuma","year":"2013","journal-title":"JACC Cardiovasc Interv."},{"key":"B6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2011.12.008","article-title":"Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?","volume":"221","author":"Brugaletta","year":"2012","journal-title":"Atherosclerosis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.amjcard.2012.01.071","article-title":"Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?","volume":"33","author":"Brugaletta","year":"2012","journal-title":"Eur Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0140-6736(17)31470-8","article-title":"2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy","volume":"390","author":"Ali","year":"2017","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1161\/CIRCULATIONAHA.117.031843","article-title":"Three-year outcomes with the absorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials","volume":"137","author":"Ali","year":"2018","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1161\/CIRCULATIONAHA.119.042584","article-title":"Clinical outcomes before and after complete everolimus-eluting bioresorbable scaffold resorption: five-year follow-up from the ABSORB III trial","volume":"140","author":"Kereiakes","year":"2019","journal-title":"Circulation."},{"key":"B11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1253\/circj.CJ-19-1184","article-title":"Long-term outcomes of absorb bioresorbable vascular scaffold vs. Everolimus-eluting metallic stent - a randomized comparison through 5 years in Japan","volume":"84","author":"Kozuma","year":"2020","journal-title":"Circul J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jamacardio.2019.4101","article-title":"Time-varying outcomes with the absorb bioresorbable vascular scaffold during 5-year follow-up: a systematic meta-analysis and individual patient data pooled study","volume":"4","author":"Stone","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jcin.2013.07.007","article-title":"A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results","volume":"7","author":"Verheye","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"key":"B14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jcin.2015.12.004","article-title":"Serial multimodality imaging and 2-year clinical outcomes of the novel DESolve novolimus-eluting bioresorbable coronary scaffold system for the treatment of single de novo coronary lesions","volume":"9","author":"Abizaid","year":"2016","journal-title":"JACC Cardiovasc Interv."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/ccd.27550","article-title":"A multicenter post-marketing evaluation of the Elixir DESolve(\u00ae) Novolimus-eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study","volume":"92","author":"Nef","year":"2018","journal-title":"Catheterizat Cardiovasc Interv."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.4244\/EIJV12I5A96","article-title":"Absorb vs. DESolve: an optical coherence tomography comparison of acute mechanical performances","volume":"12","author":"Mattesini","year":"2016","journal-title":"EuroIntervention."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S950","DOI":"10.21037\/jtd.2017.07.25","article-title":"The DESolve novolimus bioresorbable scaffold: from bench to bedside","volume":"9","author":"Mattesini","year":"2017","journal-title":"J Thorac Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.jcin.2017.07.033","article-title":"6-month clinical and angiographic outcomes of a novel radiopaque sirolimus-eluting bioresorbable vascular scaffold: the FANTOM II STudy","volume":"10","author":"Abizaid","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e000941","DOI":"10.1136\/openhrt-2018-000941","article-title":"Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study","volume":"6","author":"Simonsen","year":"2019","journal-title":"Open Heart."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e004762","DOI":"10.1161\/CIRCINTERVENTIONS.116.004762","article-title":"Comparison of acute thrombogenicity for metallic and polymeric bioabsorbable scaffolds: magmaris versus absorb in a porcine arteriovenous shunt model","volume":"10","author":"Waksman","year":"2017","journal-title":"Circul Cardiovasc Interv."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/S0140-6736(07)60853-8","article-title":"Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial","volume":"369","author":"Erbel","year":"2007","journal-title":"Lancet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.4244\/EIJ-D-15-00371","article-title":"Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial","volume":"12","author":"Haude","year":"2016","journal-title":"EuroIntervention."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1375","DOI":"10.4244\/EIJ-D-18-01000","article-title":"Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial","volume":"15","author":"Haude","year":"2020","journal-title":"EuroIntervention."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1383","DOI":"10.4244\/EIJ-D-18-01058","article-title":"Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry","volume":"15","author":"Verheye","year":"2020","journal-title":"EuroIntervention."},{"key":"B25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcin.2018.10.020","article-title":"Preclinical evaluation of a novel sirolimus-eluting iron bioresorbable coronary scaffold in porcine coronary artery at 6 months","volume":"12","author":"Zheng","year":"2019","journal-title":"JACC Cardiovasc Interv."},{"key":"B26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1021\/acsami.7b15206","article-title":"Strategy of metal-polymer composite stent to accelerate biodegradation of iron-based biomaterials","volume":"10","author":"Qi","year":"2018","journal-title":"ACS Appl Mater Interfaces."},{"key":"B27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.actbio.2017.03.020","article-title":"Long-term in vivo corrosion behavior, biocompatibility and bioresorption mechanism of a bioresorbable nitrided iron scaffold","volume":"54","author":"Lin","year":"2017","journal-title":"Acta biomaterialia."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.4244\/EIJ-D-16-00308","article-title":"Four-year polymer biocompatibility and vascular healing profile of a novel ultrahigh molecular weight amorphous PLLA bioresorbable vascular scaffold: an OCT study in healthy porcine coronary arteries","volume":"12","author":"Vahl","year":"2016","journal-title":"EuroIntervention."},{"key":"B29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ccd.28722","article-title":"First-in-man study of a thinner-strut sirolimus-eluting bioresorbable scaffold (FUTURE-I): Three-year clinical and imaging outcomes","volume":"95","author":"Song","year":"2020","journal-title":"Catheter Cardiovasc Interv."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10554-017-1148-5","article-title":"A head to head comparison of XINSORB bioresorbable sirolimus-eluting scaffold versus metallic sirolimus-eluting stent: 180 days follow-up in a porcine model","volume":"33","author":"Shen","year":"2017","journal-title":"Int J Cardiovasc Imaging."},{"key":"B31","doi-asserted-by":"publisher","first-page":"413956","DOI":"10.1155\/2012\/413956","article-title":"Comparison of acute recoil between bioabsorbable poly-L-lactic acid XINSORB stent and metallic stent in porcine model","volume":"2012","author":"Wu","year":"2012","journal-title":"J Biomed Biotechnol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41569-018-0124-7","article-title":"Fully bioresorbable vascular scaffolds: lessons learned and future directions","volume":"16","author":"Jinnouchi","year":"2019","journal-title":"Nat Rev Cardiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10554-018-1326-0","article-title":"Healing score of the Xinsorb scaffold in the treatment of de novo lesions: 6-month imaging outcomes","volume":"34","author":"Lv","year":"2018","journal-title":"Int J Cardiovasc Imaging."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.jcin.2016.03.038","article-title":"Stent thrombosis with drug-eluting stents and bioresorbable scaffolds: evidence from a network meta-analysis of 147 trials","volume":"9","author":"Kang","year":"2016","journal-title":"JACC Cardiovasc Interv."},{"key":"B35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcin.2015.09.024","article-title":"Scaffold thrombosis after percutaneous coronary intervention with ABSORB bioresorbable vascular scaffold: a systematic review and meta-analysis","volume":"9","author":"Lipinski","year":"2016","journal-title":"JACC Cardiovasc Interv."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.117.028479","article-title":"Temporal trends in adverse events after everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent implantation: a meta-analysis of randomized controlled trials","volume":"135","author":"Montone","year":"2017","journal-title":"Circulation."},{"key":"B37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcin.2016.10.027","article-title":"Very late scaffold thrombosis of bioresorbable vascular scaffold: systematic review and a meta-analysis","volume":"10","author":"Toyota","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1253\/circj.CJ-10-1160","article-title":"Characteristics and predictors of drug-eluting stent thrombosis: results from the multicenter 'Korea Stent Thrombosis (KoST)' registry","volume":"75","author":"Park","year":"2011","journal-title":"Circul J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4244\/EIJV9I1A10","article-title":"Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting","volume":"9","author":"Iqbal","year":"2013","journal-title":"EuroIntervention."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","article-title":"Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry","volume":"53","author":"van Werkum","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2011.1529","article-title":"Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis","volume":"306","author":"Cayla","year":"2011","journal-title":"JAMA."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1016\/j.jacc.2017.09.1106","article-title":"Effect of technique on outcomes following bioresorbable vascular scaffold implantation: analysis from the ABSORB trials","volume":"70","author":"Stone","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"V185","DOI":"10.4244\/EIJV11SVA44","article-title":"When and how to use BRS in bifurcations?","volume":"11","author":"Stankovic","year":"2015","journal-title":"EuroIntervention."},{"key":"B44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ccd.26634","article-title":"Bioresorbable vascular scaffold use for coronary bifurcation lesions: a substudy from GHOST EU registry","volume":"89","author":"Naganuma","year":"2017","journal-title":"Catheterizat Cardiovasc Interv."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.4244\/EIJY15M03_11","article-title":"Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds","volume":"11","author":"Panoulas","year":"2016","journal-title":"EuroIntervention."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e550","DOI":"10.4244\/EIJY15M09_10","article-title":"Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry","volume":"12","author":"Gori","year":"2016","journal-title":"EuroIntervention."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/eurheartj\/ehz074","article-title":"Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction","volume":"40","author":"R\u00e4ber","year":"2019","journal-title":"Eur Heart J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jacc.2018.02.023","article-title":"Restenosis, stent thrombosis, and bleeding complications: navigating between Scylla and Charybdis","volume":"71","author":"Torrado","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jcin.2019.09.047","article-title":"Randomized comparison between everolimus-eluting bioresorbable scaffold and metallic stent: multimodality imaging through 3 years","volume":"13","author":"Onuma","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1016\/j.jacc.2017.09.075","article-title":"Mechanisms of very late bioresorbable scaffold thrombosis: the INVEST registry","volume":"70","author":"Yamaji","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1580","DOI":"10.4244\/EIJV11I14A308","article-title":"The use of a scoring balloon for optimal lesion preparation prior to bioresorbable scaffold implantation: a comparison with conventional balloon predilatation","volume":"11","author":"Miyazaki","year":"2016","journal-title":"EuroIntervention."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jcin.2015.07.026","article-title":"Relation between bioresorbable scaffold sizing using QCA-Dmax and clinical outcomes at 1 year in 1,232 patients from 3 study cohorts (ABSORB cohort B, ABSORB EXTEND, and ABSORB II)","volume":"8","author":"Ishibashi","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"B53","first-page":"E34","article-title":"Minimal acute recoil following bioresorbable scaffold implantation in fibrocalcific lesion detected by optical frequency-domain imaging","volume":"28","author":"Kawamoto","year":"2016","journal-title":"J Invasive Cardiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.4244\/EIJ-D-16-00471","article-title":"Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging","volume":"12","author":"Sotomi","year":"2017","journal-title":"EuroIntervention."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/S0140-6736(16)32050-5","article-title":"Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial","volume":"388","author":"Serruys","year":"2016","journal-title":"Lancet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","article-title":"A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.4244\/EIJ-D-17-00796","article-title":"Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial","volume":"14","author":"Xu","year":"2018","journal-title":"EuroIntervention."},{"key":"B58","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10554-011-9829-y","article-title":"Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT","volume":"28","author":"Guti\u00e9rrez-Chico","year":"2012","journal-title":"Int J Cardiovasc Imaging."},{"key":"B59","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ijcard.2016.07.033","article-title":"Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds","volume":"221","author":"Caiazzo","year":"2016","journal-title":"Int J Cardiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ccd.25378","article-title":"Expansion and malapposition characteristics after bioresorbable vascular scaffold implantation","volume":"84","author":"Brown","year":"2014","journal-title":"Catheterizat Cardiovasc Interv."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1093\/eurheartj\/ehx155","article-title":"Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials","volume":"38","author":"Collet","year":"2017","journal-title":"Eur Heart J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.4244\/EIJ-D-17-00119","article-title":"Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months","volume":"13","author":"Felix","year":"2017","journal-title":"EuroIntervention."},{"key":"B64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy855","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2020.589571\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T23:34:07Z","timestamp":1606692847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2020.589571\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":64,"alternative-id":["10.3389\/fcvm.2020.589571"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2020.589571","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]},"article-number":"589571"}}